Product image of Minirin Spray (Desmopressin Acetate) supplied by GNH India

Minirin Spray

Active Ingredient:
Desmopressin Acetate
Origin:
EU

Minirin Spray (Desmopressin Acetate)

Desmopressin acetate, the active ingredient in Minirin Spray, is a vasopressin analog presented as a 10 µg per spray nasal spray for nasal use. It is employed to manage central diabetes insipidus and nocturnal enuresis in patients requiring antidiuretic therapy.

GNH India supplies Minirin Spray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution originating from the European Union market. The company adheres to stringent quality standards and provides regulatory documentation for global procurement.

Manufacturer / TM Owner

Ferring N.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Desmopressin acetate acts on the antidiuretic hormone pathway and is indicated for the following conditions:

  • Central diabetes insipidus: reduces excessive urine output by enhancing water reabsorption in the kidneys.
  • Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine.

How It Works

  • Desmopressin acetate selectively binds to V2 receptors on the basolateral membrane of renal collecting‑duct cells. This activation stimulates adenylate cyclase, increasing cyclic AMP levels, which promote the insertion of aquaporin‑2 water channels into the apical membrane, thereby enhancing water reabsorption and concentrating urine.

Side Effects

Desmopressin nasal spray may cause a range of adverse reactions.

Common Side Effects

  • Nasal irritation or congestion: mild discomfort at the application site.
  • Headache: transient and usually mild.
  • Mild hyponatremia: low sodium levels without severe symptoms.
  • Thirst: increased sensation of dryness.
  • Nausea: occasional upset stomach.
  • Facial flushing: temporary redness of the skin.

Serious or Rare Side Effects

  • Severe hyponatremia: marked sodium depletion that can lead to neurological symptoms.
  • Seizures: convulsive episodes associated with electrolyte imbalance.
  • Allergic reaction: rash, itching, or swelling.
  • Nasal septum perforation: rare structural damage to nasal tissue.
  • Water intoxication: excessive water retention causing cerebral edema.

Precautions & Warnings

Before prescribing Minirin Spray, clinicians should consider several safety measures.

  • Assess serum sodium: check baseline levels to avoid hyponatremia.
  • Monitor fluid intake: advise patients to limit excessive water consumption.
  • Avoid concurrent antidiuretic agents: reduce risk of severe sodium loss.
  • Use cautiously in renal impairment: adjust monitoring frequency.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Desmopressin acetate can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Concomitant use with other vasopressin analogs: risk of severe hyponatremia.
  • Combination with carbamazepine or other hyponatremia‑inducing drugs: additive effect on sodium loss.
  • Use with diuretics (especially thiazides): may potentiate water retention.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may reduce renal clearance of desmopressin.
  • Alcohol: can increase the risk of hyponatremia.
  • Antidepressants (SSRIs): potential additive hyponatremia effect.

Frequently Asked Questions

Minirin Spray contains desmopressin acetate and is prescribed to treat central diabetes insipidus, a condition characterized by excessive urine output, and to reduce nighttime bedwetting (nocturnal enuresis) by concentrating the urine.

Desmopressin acetate is a selective V2‑receptor agonist. By activating these receptors in the kidney’s collecting ducts, it increases cyclic AMP, which promotes insertion of aquaporin‑2 channels, allowing more water to be reabsorbed and resulting in concentrated urine.

The exact dose of Minirin Spray is determined by the prescribing healthcare professional based on the patient’s condition, age, and response. Dosage may be adjusted after evaluating clinical effectiveness and laboratory parameters.

Safety data for desmopressin acetate during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Minirin Spray, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative to nasal desmopressin is oral desmopressin tablets. Nasal administration can provide a more rapid onset and may be preferred when oral intake is problematic, but tablets offer convenient dosing without the need for a spray device. Both share the same mechanism and safety profile.

Store Minirin Spray at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and avoid exposing the spray to extreme temperatures that could affect potency.

The spray is administered into one nostril while the patient is upright. Typically, one spray (10 µg) is delivered per dose, but the exact regimen is set by the prescriber. The patient should avoid blowing the nose immediately after dosing.

The most critical risks include severe hyponatremia, which can cause confusion, seizures, or coma, and water intoxication leading to cerebral edema. Patients should be monitored for sudden changes in mental status, excessive weight gain, or persistent nausea.

Minirin Spray is contraindicated in patients with known hypersensitivity to desmopressin, existing hyponatremia, uncontrolled severe renal impairment, or those taking other antidiuretic agents that could precipitate dangerous fluid retention.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Desmopressin Acetate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT